Interaction between lymphotropic cytostatic treatment and lymphocytic choriomeningitis virus infection in mice.
D000818:Animals; D000956:Antigens, Viral; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001769:Blood / Q000382:microbiology; D001921:Brain / Q000382:microbiology / Q000473:pathology; D003168:Complement Fixation Tests; D004988:Ethers, Cyclic / Q000627:therapeutic use; D004376:Galactitol / Q000627:therapeutic use; D008216:Lymphocytic Choriomeningitis / Q000276:immunology*; D008217:Lymphocytic choriomeningitis virus / Q000276:immunology / Q000302:isolation & purification; D051379:Mice; D008936:Mitolactol / Q000627:therapeutic use
D000956:Antigens, Viral; D000970:Antineoplastic Agents; D004988:Ethers, Cyclic; D004376:Galactitol; D008936:Mitolactol